GlassScriptPhysician profile
Sebastian R Herrera
NPI 1851541338
$1,241.71
in general payments reported to CMS, 2019-2025
14 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.00 · 2021: $39.84 · 2022: $154 · 2023: $102 · 2024: $274 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $392.16 | 2021-2025 | Excelsius Gps, Sable, Excelsius3d Imaging System |
| Stryker Corporation | $248.49 | 2022-2025 | Everest Spinal System |
| Alphatec Spine, INC | $107.14 | 2024 | |
| Abbvie INC. | $102.60 | 2025 | |
| Medtronic, INC. | $84.91 | 2021-2024 | Mazor X System |
| Astrazeneca Pharmaceuticals LP | $76.19 | 2023-2024 | Andexxa |
| Integra Lifesciences Corporation | $50.49 | 2023-2024 | Codman Certas, Codman Hakim, Cusa Clarity |
| Merz Pharmaceuticals, LLC | $43.00 | 2022-2024 | Xeomin |
| Siemens Medical Solutions USA, INC. | $37.62 | 2025 | Artis Pheno |
| Nevro Corp. | $28.00 | 2020 | |
| Davol INC. | $23.44 | 2023 | Arista Ah Flexitip |
| Novartis Pharmaceuticals Corporation | $17.10 | 2025 | |
| Providence Medical Technology, INC. | $16.02 | 2025 | |
| Boston Scientific Corporation | $14.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sebastian Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.